2021
DOI: 10.1001/jamanetworkopen.2020.37346
|View full text |Cite
|
Sign up to set email alerts
|

Representation of Women on National Institutes of Health Study Sections

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
18
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(18 citation statements)
references
References 6 publications
0
18
0
Order By: Relevance
“…At present, the three organizations examined herein have boards of directors comprising 44% women (8 of 18) at ADA (25), 33% (5 of 15) at JDRF (26), and 25% (3 of 12) at EASD (27). Additionally, when Volerman et al (28) examined study sections from one 2019 cycle of NIH funding, they found men were more likely to be reviewers and chairs, whereas women were more likely to hold less influential positions, including temporary affiliations and serving on study sections with lower total funding dollars or number of research grant awards. Indeed, in order to identify possible remedies for this clearly pervasive situation, there remains a need to more precisely identify the various stages in the career pipeline where inequities arise (e.g., promotion and tenure, award nomination, and selection committee bias) in addition to those reported here (editorial board participation, receipt of grant funding, and award recipients), altogether contributing toward the dilution of women from upper levels of leadership.…”
Section: Discussionmentioning
confidence: 99%
“…At present, the three organizations examined herein have boards of directors comprising 44% women (8 of 18) at ADA (25), 33% (5 of 15) at JDRF (26), and 25% (3 of 12) at EASD (27). Additionally, when Volerman et al (28) examined study sections from one 2019 cycle of NIH funding, they found men were more likely to be reviewers and chairs, whereas women were more likely to hold less influential positions, including temporary affiliations and serving on study sections with lower total funding dollars or number of research grant awards. Indeed, in order to identify possible remedies for this clearly pervasive situation, there remains a need to more precisely identify the various stages in the career pipeline where inequities arise (e.g., promotion and tenure, award nomination, and selection committee bias) in addition to those reported here (editorial board participation, receipt of grant funding, and award recipients), altogether contributing toward the dilution of women from upper levels of leadership.…”
Section: Discussionmentioning
confidence: 99%
“…I took a biased approach and mentioned two extraordinary female Nobel Prize winners, Gerty Cori and Rita Levi-Montalcini, but in reality, only 12 of 111 prizes in medicine have been awarded to women (4). In contrast with other trends, the number of female physicians in leadership roles at academic centers has not increased over a 35-year period, instead remaining stagnant at 25% less than that for males (10), as has women's representation on National Institutes of Health study sections (11).…”
Section: Immigrants Leading Biomedical Researchmentioning
confidence: 86%
“…11 This is yet another impetus to address the gender disparities in research scholar tracks, academic departments concerning promotion and retention, as well as within NIH study sections, where women remain underrepresented as chairs and reviewers. 13 Finally, more data are needed to provide insight into the apparent underrepresentation of NIH-funded cardiac anesthesiologists, who attract a mere 3.5% of anesthesiology funding. It is unclear if this disparity is unique to cardiac anesthesiology, or reflects a broader reluctance of anesthesiologist-scientistswith increasing pressure to produce academically-to complete a clinical fellowship.…”
mentioning
confidence: 99%